Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chimeric Therapeutics Ltd. ( (AU:CHM) ) has shared an announcement.
Chimeric Therapeutics Limited announced the quotation of 164,307,917 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of a previously announced transaction, which may enhance the company’s market presence and provide additional capital for its ongoing research and development efforts in cancer therapies.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Limited operates in the biotechnology industry, focusing on the development of innovative therapies. The company is primarily engaged in the research and development of cell therapies for cancer treatment, aiming to provide advanced solutions in oncology.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.4M
Find detailed analytics on CHM stock on TipRanks’ Stock Analysis page.